A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.
Dickens AM, Larkin JR, Griffin JL, Cavey A, Matthews L, Turner MR, Wilcock GK, Davis BG, Claridge TD, Palace J, Anthony DC, Sibson NR.
Dickens AM, et al. Among authors: sibson nr.
Neurology. 2014 Oct 21;83(17):1492-9. doi: 10.1212/WNL.0000000000000905. Epub 2014 Sep 24.
Neurology. 2014.
PMID: 25253748
Free PMC article.